1. Academic Validation
  2. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK

Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK

  • Bioorg Med Chem Lett. 2010 Dec 15;20(24):7303-7. doi: 10.1016/j.bmcl.2010.10.066.
Roy K Hom 1 Simeon Bowers Jennifer M Sealy Anh P Truong Gary D Probst Martin L Neitzel R Jeffrey Neitz Larry Fang Louis Brogley Jing Wu Andrei W Konradi Hing L Sham Gergely Tóth Hu Pan Nanhua Yao Dean R Artis Kevin Quinn John-Michael Sauer Kyle Powell Zhao Ren Frédérique Bard Ted A Yednock Irene Griswold-Prenner
Affiliations

Affiliation

  • 1 Department of Chemical Sciences, Elan Pharmaceuticals, South San Francisco, CA 94080, USA. roy.hom@elan.com
Abstract

From high throughput screening, we discovered compound 1, the prototype for a series of disubstituted thiophene inhibitors of JNK which is selective towards closely related MAP kinases p38 and ERK2. Herein we describe the evolution of these compounds to a novel class of thiophene and thiazole JNK inhibitors that retain favorable solubility, permeability, and P-gp properties for development as CNS agents for treatment of neurodegeneration. Compound 61 demonstrated JNK3 IC(50)=77 nM and retained the excellent broad kinase selectivity observed for the series.

Figures
Products